Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
RESEARCH TOOLSreports
Holding XERS?
Track your performance easily
Xeris Pharmaceuticals (XERS) Ownership Overview
13.37% Insiders
8.28% Mutual Funds
11.06% Other Institutional Investors
― ETFs
67.29% Public Companies and
Individual Investors
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. , 13.37% is owned by Insiders, and 67.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 10, 2024 | John Schmid Director | xxxxxxxxxxxxx | $10314 |
| Mar 14, 2024 | John Schmid Director | xxxxxxxxxxxxx | $9720 |
| Nov 29, 2023 | Jeffrey W. Sherman Director | xxxxxxxxxxxxx | $10098 |
| Nov 21, 2023 | Dawn Halkuff Director | xxxxxxxxxxxxx | $9954 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $8758 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $162589 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $191427 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,121,672 | Institution | 4.80% | 16,771,538 | |
| 6,373,250 | Institution | 4.30% | 15,009,004 | |
| 5,352,753 | Institution | 3.61% | 12,605,733 | |
| 1,397,674 | Institution | 0.94% | 3,291,522 | |
| 1,389,278 | Institution | 0.94% | 3,271,750 | |
| 689,764 | Institution | 0.47% | 1,624,394 | |
| 613,730 | Institution | 0.41% | 1,445,334 | |
| 546,205 | Institution | 0.37% | 1,286,313 | |
| 508,545 | Institution | 0.34% | 1,197,623 | |
| 364,382 | Institution | 0.25% | 858,120 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,373,250 | Institution | 4.30% | 15,009,004 | |
| 1,397,674 | Institution | 0.94% | 3,291,522 | |
| 1,389,278 | Institution | 0.94% | 3,271,750 | |
| 689,764 | Institution | 0.47% | 1,624,394 | |
| 613,730 | Institution | 0.41% | 1,445,334 | |
| 546,205 | Institution | 0.37% | 1,286,313 | |
| 364,382 | Institution | 0.25% | 858,120 | |
| 244,436 | Institution | 0.16% | 575,647 | |
| 84,399 | Institution | 0.06% | 198,760 | |
| 76,499 | Institution | 0.05% | 180,155 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,254,957 | Institution | 2.87% | 9,594,928 | |
| 3,404,231 | Institution | 2.30% | 7,965,901 | |
| 2,140,601 | Institution | 1.44% | 4,827,055 | |
| 1,228,402 | Institution | 0.83% | 2,892,887 | |
| 503,635 | Institution | 0.34% | 1,135,697 | |
| 357,759 | Institution | 0.24% | 837,156 | |
| 302,243 | Institution | 0.20% | 711,782 | |
| 228,207 | Institution | 0.15% | 534,004 | |
| 119,126 | Institution | 0.08% | 268,629 | |
| 82,133 | Institution | 0.06% | 192,191 |
FAQ
Who Owns Xeris Pharmaceuticals (XERS)?
According to the latest TipRanks data, approximately 11.06% of the company's stock is held by institutional investors, 13.37% is held by insiders, and 67.29% is held by retail investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.06% of Xeris Pharmaceuticals (XERS) stock is held by institutional investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.29% of Xeris Pharmaceuticals (XERS) stock is held by retail investors.
Who owns the most shares of Xeris Pharmaceuticals (XERS)?
Vanguard owns the most shares of Xeris Pharmaceuticals (XERS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.